May 28, 2025
4,475
44
16
1.34%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
5:04Now PlayingWhen it was approved last year it was heralded as a breakthrough treatment in the fight against a rare and incurable muscle wasting disease. Givinostat slows the progression of Duchenne Muscular Dystrophy, a genetic condition which mainly affects young boys.
The drug was offered to hospital trusts for free under an early access programme. But to the dismay of parents, many trusts in England are refusing to make it available on cost grounds.
(Subscribe)
-----------------------
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.